Original filing (PDF)20251008075417NAL0002835171001

GOODWIN BIOTECHNOLOGY, INCORPORATED

Name: GOODWIN BIOTECHNOLOGY, INCORPORATED — GOODWIN BIOTECHNOLOGY 401(K) PLAN, Form 5500 (2024)
Creator: GOODWIN BIOTECHNOLOGY, INCORPORATED

Form 5500-SF

FILING_RECEIVED

GOODWIN BIOTECHNOLOGY 401(K) PLAN

401(k) retirement plan

Active participants

Accounts w/ balance

Plan assets (EOY)

$2.8M

Net assets (EOY)

$2.8M

Plan health score (directional)

/ 100

Grade A

Top-tier plan health

Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.

Compliance & disclosures

100

Concentration risk

Total plan cost

Vendor stack

100

Participation health

Decision-maker contacts

CFO / Head of HR / Benefits Manager — verified email + LinkedIn for GOODWIN BIOTECHNOLOGY, INCORPORATED.

Plan sponsor

Name

GOODWIN BIOTECHNOLOGY, INCORPORATED

EIN

65-0368262

Address

1850 NW 69TH AVENUE · PLANTATION, FL · 33313

Phone

(954) 327-9645

Industry

Manufacturingsee all

Plan administrator

Same as plan sponsor.

Plan characteristics

Plan number

001

Plan year

2024

Plan year begin

2024-01-01

Tax period

2024-12-31

Filed

2025-10-08

Pension benefit codes

2E · Profit-sharing

2F · ERISA section 404(c)

2G · Total participant-directed accounts

2J · 401(k) feature

2K · 401(m) arrangement

2T · Default investment account (QDIA)

3D · Pre-approved plan (master / prototype / VS)

Audit & trust (Schedule H)

Service providers (Schedule C)

Small plans don't disclose service providers

Related plans

Similar-size Manufacturing plans

THERATECHNOLOGIES U.S., INC.

THERATECHNOLOGIES U.S., INC. 401(K) PLAN

$2.8M · 41 participants

OCULAR SCIENCE, INC.

OCULAR SCIENCE & AFFILIATES 401(K) PLAN

$2.8M · 121 participants

SUMMIT THERAPEUTICS INC.

SUMMIT THERAPEUTICS INC. 401(K) PLAN

$2.8M · 40 participants

TAIMED BIOLOGICS USA

TAIMED BIOLOGICS USA 401K

$2.8M · 3 participants

SAFE N SIMPLE, L.L.C.

SAFE N SIMPLE, L.L.C. CASH BALANCE PLAN

$2.8M · 14 participants